Endo International Plc has attempted multiple times to buy Salix Pharmaceuticals Ltd. but has been rejected by the drugmaker, according to a Reuters article.
Endo and its advisers have sent several letters to the company, and it remains interested in a potential takeover, said an unnamed source.
Valeant Pharmaceuticals International and Shire Plc have also attempted a bid for Salix, sources previously told Reuters. Read the full article
